ABOUT US

Every company has been shaped by moments of inspiration, perseverance, courage, luck and seamless partnership. Ronnsi Remedium Sdn Bhd was born in compelling entrepreneurship and collaboration with a formidable Pharmaceutical company, Suzhou Ronnsi Pharma Co., Ltd - China — a company with significant achievements, such as patents and State of Art Research and Development.

BUSINESS WE DO

Ronnsi Remedium Sdn Bhd operates business on the ASEAN Regional Scale with strong customer ties Focusing On Innovative Healthcare products and generic drugs.

OUR MISSION

To preserve and improve patients' health by consistently delivering high-quality, safe, and effective pharmaceutical products and services that meet customers' expectations worldwide through current good manufacturing practices, state-of-the-art technology, a competent workforce, and efficient management.

OUR VISION

To be the leading pharmaceutical company in Malaysia regarding expertise, innovation, and responsible entrepreneurship. We want to make a visible presence in the international markets with our high-quality products & services.

OUR VALUES

ETHICS AND RESPONSIBILITY: We take care of our employees, our patients, and our consumers. The respect of the highest ethical standards is the basis of all our actions and decisions oriented by a long-term perspective.

We have committed to ensuring the sustainable economic development of the company, to safeguarding the environment, and the communities in which we operate in.

MEET THE TEAM

DATO’ JAMALLUDIN ELLIS

DR RAADJEV JAYARMAN

AHAMAD SIDIQUE

TEO CHOON HENG

PATRCIA WONG

(Director & Chief Executive Officer)

(Director)

(Director)

(Director)

(Director)

OUR HISTORY

Every company has been shaped by moments of inspiration, perseverance, courage, luck, or seamless partnership.

Ronnsi Remedium Sdn Bhd was born in compelling entrepreneurship and partnership with a formidable Pharmaceutical company, Suzhou Ronnsi Pharma Co., Ltd - China. A company with significant achievements, such as patents and State of Art Research and Development

est. 2022

END USERS

MINISTRY OF HEALTH OWNED PUBLIC HOSPITALS

Participating Procurement Exercise:

  • APPL (Approved Price Product List for Concessionaires)

  • E-TENDERS

  • BUMI AGENT TENDERS